Cargando…
Detection of circulating BMP5 as a risk factor for Barrett’s esophagus
Barrett’s esophagus (BE) predisposes for the malignant condition of esophageal adenocarcinoma (EAC). Since BE patients have few or no symptoms, most of these patients are not identified and not included in surveillance programs. These BE patients are at risk of developing advanced-stage EAC. At pres...
Autores principales: | Correia, Ana C. P., Calpe, Silvia, Mostafavi, Nahid, Hoefnagel, Sanne Johanna Maria, Sancho-Serra, Maria del Carmen, de Koning, Patricia S., Krishnadath, Kausilia K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511298/ https://www.ncbi.nlm.nih.gov/pubmed/32968094 http://dx.doi.org/10.1038/s41598-020-70760-1 |
Ejemplares similares
-
Comparison of newly developed anti-bone morphogenetic protein 4 llama-derived antibodies with commercially available BMP4 inhibitors
por: Calpe, Silvia, et al.
Publicado: (2016) -
Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models
por: Li, Shulin, et al.
Publicado: (2022) -
Single domain Camelid antibody fragments for molecular imaging and therapy of cancer
por: Li, Shulin, et al.
Publicado: (2023) -
Molecular Biology and Clinical Management of Esophageal Adenocarcinoma
por: Li, Shulin, et al.
Publicado: (2023) -
Inhibition of the BMP pathway prevents development of Barrett’s-associated adenocarcinoma in a surgical rat model
por: Westra, Wytske M, et al.
Publicado: (2021)